Pan American Silver Corp. (NY:PAAS)
Price and Volume
Detailed Quote| Volume | 6,313,012 |
| Open | 36.81 |
| Bid (Size) | 38.30 (1,300) |
| Ask (Size) | 38.40 (500) |
| Prev. Close | 39.05 |
| Today's Range | 36.65 - 38.80 |
| 52wk Range | 19.80 - 42.57 |
| Shares Outstanding | 210,258,667 |
| Dividend Yield | 1.04% |
Top News
More NewsPerformance
More News
Read More
Silver's Shimmering Ascent: A Dual-Powered Bull Run Ignites the Market
November 13, 2025
Silver Soars to Unprecedented Highs, Spearheading a Precious Metals Boom
November 13, 2025
Silver Shines Bright: A Dual-Powered Bull Run on the Horizon
November 13, 2025
Silver's Post-Shutdown Retreat: A Nuanced Market Rebalancing Act
November 13, 2025
Why Is Pan American Silver (PAAS) Stock Trending Overnight/ ↗
November 13, 2025
Pan American Silver Reports Unaudited Third Quarter 2025 Results
November 12, 2025
Frequently Asked Questions
Is Pan American Silver Corp. publicly traded?
Yes, Pan American Silver Corp. is publicly traded.
What exchange does Pan American Silver Corp. trade on?
Pan American Silver Corp. trades on the New York Stock Exchange
What is the ticker symbol for Pan American Silver Corp.?
The ticker symbol for Pan American Silver Corp. is PAAS on the New York Stock Exchange
What is the current price of Pan American Silver Corp.?
The current price of Pan American Silver Corp. is 38.51
When was Pan American Silver Corp. last traded?
The last trade of Pan American Silver Corp. was at 11/14/25 07:00 PM ET
What is the market capitalization of Pan American Silver Corp.?
The market capitalization of Pan American Silver Corp. is 8.10B
How many shares of Pan American Silver Corp. are outstanding?
Pan American Silver Corp. has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.